The Adapted POM Analysis of Avenanthramides In Silico

Number of the records: 1

Title	The Adapted POM Analysis of Avenanthramides In Silico
Author	Maliar T.
Co-authors	Maliarová Mária
	Purdešová Andrea
	Jankech Timotej SAVNEIMU - Neuroimunologický ústav SAV
	Gerhardtová Ivana SAVNEIMU - Neuroimunologický ústav SAV
	Beňovič Patrik
	Viskupičová Jana 1983- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV ^SCOPUS

Co-authors	Dvořáček Václav Jágr Michal
Source document	Pharmaceuticals. Vol. 16, no. 5 (2023), art. no. 717
Language	eng - English
Country	CH - Switzerland
Note	SRDA-20-0413, NAZV QK1810102
Document kind	rozpis článkov z periodík (rbx)
Citations	ALMINDEREJ, F. - GHANNAY, S. - ELSAMANI, M.O. - ALHAWDAY, F. - ALBADRI, A.E.A.E. - ELBEHAIRI, S.E.I. - ALFAIFI, M.Y. - KADRI, A. - AOUADI, K. In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers. In PHARMACEUTICALS. JUL 2023, vol. 16, no. 7. Dostupné na: https://doi.org/10.3390/ph16071025.
Category	ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
Category of document (from 2022)	V3 - Vedecký výstup publikačnej činnosti z časopisu
Type of document	článok
Year	2023
Registered in	WOS
Registered in	SCOPUS
Registered in	CCC
DOI	10.3390/ph16050717

article

	File name	Access	Size	Downloaded	Type	License
	The Adapted POM Analysis of Avenanthramides In Silico.pdf	available	1.5 MB	6	Publisher's version

rok	CC	IF	IF Q (best)	JCR Av Jour IF Perc	SJR	SJR Q (best)	CiteScore
	A

rok vydania	rok metriky	IF	IF Q (best)	SJR	SJR Q (best)
2023	2022	4.6	Q2	0.799	Q1

Number of the records: 1